Jiri Bartek Selected Research

BP-1-102

12/2021

Design, synthesis, and in vitro evaluation of BP-1-102 analogs with modified hydrophobic fragments for STAT3 inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiri Bartek Research Topics

Disease

101	Neoplasms (Cancer) 04/2022 - 06/2002
16	Breast Neoplasms (Breast Cancer) 12/2016 - 06/2002
14	Genomic Instability 01/2021 - 05/2004
11	Carcinogenesis 01/2022 - 11/2006
11	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 08/2008
10	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2020 - 04/2003
9	Glioma (Gliomas) 01/2022 - 01/2017
7	Infections 01/2022 - 02/2016
7	Brain Neoplasms (Brain Tumor) 01/2021 - 08/2008
5	Alcoholism (Alcohol Abuse) 01/2022 - 12/2017
5	Carcinoma (Carcinomatosis) 01/2021 - 10/2003
5	Ovarian Neoplasms (Ovarian Cancer) 10/2016 - 01/2011
4	Meningioma (Meningiomas) 10/2022 - 04/2016
4	Chromosomal Instability (Chromosome Stability) 10/2021 - 12/2007
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2020 - 01/2017
4	Medulloblastoma 01/2020 - 01/2017
4	Retinoblastoma (Glioblastoma, Retinal) 11/2006 - 07/2002
3	Hydrocephalus (Hydrocephaly) 01/2022 - 02/2016
3	Melanoma (Melanoma, Malignant) 01/2021 - 11/2014
3	Astrocytoma (Pilocytic Astrocytoma) 01/2021 - 01/2008
3	Disease Progression 10/2020 - 01/2016
3	Lung Neoplasms (Lung Cancer) 07/2020 - 11/2011
3	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 11/2013
3	Chronic Subdural Hematoma 05/2018 - 06/2017
2	Brain Abscess (Abscess, Brain) 12/2021 - 01/2016
2	Acoustic Neuroma (Acoustic Neurinoma) 01/2021 - 01/2017
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2020 - 01/2016
2	Inflammation (Inflammations) 04/2020 - 01/2012
2	Neoplasm Metastasis (Metastasis) 01/2020 - 09/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 06/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2019 - 01/2016
2	Hematoma 11/2017 - 04/2016
2	Hemorrhage 01/2017 - 04/2016
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2017 - 11/2014

Drug/Important Bio-Agent (IBA)

35	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2002
26	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2003
21	Phosphotransferases (Kinase)IBA 01/2020 - 08/2002
14	Pharmaceutical PreparationsIBA 01/2022 - 08/2010
12	Biomarkers (Surrogate Marker)IBA 10/2022 - 10/2012
8	Biological ProductsIBA 01/2018 - 06/2005
7	CopperIBA 01/2022 - 12/2017
7	Disulfiram (Antabuse)FDA Link 01/2022 - 12/2017
6	CytokinesIBA 09/2017 - 01/2008
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 10/2012
5	CyclinsIBA 06/2014 - 10/2002
4	ChromatinIBA 01/2022 - 04/2006
4	EnzymesIBA 10/2021 - 04/2012
4	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 06/2003
4	Messenger RNA (mRNA)IBA 01/2021 - 11/2004
4	Small Interfering RNA (siRNA)IBA 01/2020 - 10/2003
4	AntigensIBA 01/2018 - 01/2017
4	AnthracyclinesIBA 06/2015 - 07/2008
4	Histones (Histone)IBA 12/2007 - 07/2004
3	Ditiocarb (Sodium Diethyldithiocarbamate)FDA Link 01/2022 - 12/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 01/2018
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 01/2017
3	GoldIBA 01/2021 - 10/2016
3	Cyclin DIBA 01/2021 - 10/2002
3	Protein Kinases (Protein Kinase)IBA 04/2020 - 04/2003
3	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2020 - 07/2008
3	RNA (Ribonucleic Acid)IBA 10/2019 - 11/2017
3	Azacitidine (5 Azacytidine)FDA Link 01/2019 - 01/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2012 - 01/2008
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022 - 05/2015
2	Transcription Factors (Transcription Factor)IBA 12/2021 - 10/2018
2	Poly Adenosine Diphosphate RiboseIBA 11/2021 - 11/2018
2	Antidepressive Agents (Antidepressants)IBA 01/2021 - 01/2021
2	Retinoblastoma ProteinIBA 01/2021 - 02/2003
2	Hypnotics and Sedatives (Sedatives)IBA 01/2021 - 01/2021
2	polycationsIBA 10/2019 - 01/2017
2	InterferonsIBA 01/2019 - 08/2012
2	Interferon-gamma (Interferon, gamma)IBA 01/2019 - 02/2016
2	MethyltransferasesIBA 04/2018 - 01/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 09/2002
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 09/2010
2	SurvivinIBA 01/2018 - 01/2017
2	MesothelinIBA 10/2017 - 09/2017
2	olaparibIBA 02/2016 - 05/2015
2	Interleukin-8 (Interleukin 8)IBA 01/2016 - 12/2012
2	Cyclin D1IBA 01/2016 - 11/2006
2	Interleukin-6 (Interleukin 6)IBA 12/2012 - 08/2012
2	CamptothecinIBA 10/2012 - 08/2010
2	ParaffinIBA 09/2012 - 02/2011
2	UbiquitinIBA 08/2012 - 04/2012
2	Promyelocytic Leukemia ProteinIBA 08/2012 - 08/2010
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2012 - 08/2008
2	Monoclonal AntibodiesIBA 11/2011 - 06/2005
2	Cadherins (E-Cadherin)IBA 11/2011 - 01/2011
2	A-factor (Streptomyces)IBA 11/2011 - 08/2008

Therapy/Procedure

46	Therapeutics 04/2022 - 05/2003
18	Drug Therapy (Chemotherapy) 01/2022 - 01/2008
7	Radiotherapy 09/2017 - 01/2008
4	Extracorporeal Membrane Oxygenation 01/2020 - 01/2017
4	Laser Therapy (Surgery, Laser) 01/2020 - 07/2019
3	Craniotomy 01/2022 - 04/2016
3	Lasers (Laser) 01/2020 - 01/2016
2	Ventriculoperitoneal Shunt 07/2019 - 02/2016
2	Immunotherapy 04/2018 - 08/2016
2	Hyperbaric Oxygenation 01/2018 - 01/2016
2	Adjuvant Chemotherapy 04/2012 - 07/2008